Stollings Lindsay M, Jia Li-Jie, Tang Pei, Dou Huanyu, Lu Binfeng, Xu Yan
Departments of Anesthesiology (L.M.S., P.T., Y.X.), Immunology (B.L.), Pharmacology and Chemical Biology (P.T., Y.X.), Computational and Systems Biology (P.T.), and Structural Biology (Y.X.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (L.-J.J.); and Department of Biomedical Sciences, Texas Tech University Health Sciences Center, El Paso, Texas (H.D.).
Anesthesiology. 2016 Aug;125(2):399-411. doi: 10.1097/ALN.0000000000001195.
Volatile general anesthetics continue to be an important part of clinical anesthesia worldwide. The impact of volatile anesthetics on the immune system has been investigated at both mechanistic and clinical levels, but previous studies have returned conflicting findings due to varied protocols, experimental environments, and subject species. While many of these studies have focused on the immunosuppressive effects of volatile anesthetics, compelling evidence also exists for immunoactivation. Depending on the clinical conditions, immunosuppression and activation due to volatile anesthetics can be either detrimental or beneficial. This review provides a balanced perspective on the anesthetic modulation of innate and adaptive immune responses as well as indirect effectors of immunity. Potential mechanisms of immunomodulation by volatile anesthetics are also discussed. A clearer understanding of these issues will pave the way for clinical guidelines that better account for the impact of volatile anesthetics on the immune system, with the ultimate goal of improving perioperative management.
挥发性全身麻醉药仍然是全球临床麻醉的重要组成部分。挥发性麻醉药对免疫系统的影响已在机制和临床层面进行了研究,但由于方案、实验环境和受试物种的不同,以往的研究结果相互矛盾。虽然这些研究大多集中在挥发性麻醉药的免疫抑制作用上,但也有令人信服的免疫激活证据。根据临床情况,挥发性麻醉药引起的免疫抑制和激活可能有害也可能有益。本综述对挥发性麻醉药对先天性和适应性免疫反应以及免疫间接效应器的麻醉调节作用提供了一个平衡的观点。还讨论了挥发性麻醉药免疫调节的潜在机制。对这些问题更清晰的理解将为更好地考虑挥发性麻醉药对免疫系统影响的临床指南铺平道路,最终目标是改善围手术期管理。